Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1324, 2002-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Update on UK NICE interferon- /glatiramer acetate appraisal
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 298, 2001-01 ,pp. :
UK NICE rules against interferon- and glatiramer acetate in FAD
Inpharma, Vol. 1, Iss. 1314, 2001-01 ,pp. :
UK NICE issues guidance on temozolomide for brain cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 311, 2001-01 ,pp. :
UK NICE issues guidance on infliximab in Crohn's disease
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 363, 2002-01 ,pp. :
UK NICE issues guidance on temozolomide for brain cancer
Inpharma, Vol. 1, Iss. 1286, 2001-01 ,pp. :